UiPath Inc.
General ticker "PATH" information:
- Sector: Information Technology
- Industry: Software - Infrastructure
- Capitalization: $7.1B (TTM average)
UiPath Inc. follows the US Stock Market performance with the rate: 12.2%.
Estimated limits based on current volatility of 4.0%: low 11.68$, high 12.66$
Factors to consider:
- Total employees count: 4035 (+5.3%) as of 2024
- North and South America accounted for 48.3% of revenue in the fiscal year ended 2024-01-31
- Top business risk factors: Operational and conduct risks, Market competition, Cybersecurity threats, Dependency on business automation platform, Geopolitical risks
- Earnings for 3 months up through Q1 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2026-01-31 to 2028-01-31
- 2026-01-31 to 2027-01-31 estimated range: [11.97$, 19.77$]
- 2027-01-31 to 2028-01-31 estimated range: [13.11$, 21.45$]
Financial Metrics affecting the PATH estimates:
- Positive: with PPE of 19.7 at the end of fiscal year the price was very low
- Positive: -5.39 < Operating profit margin, % of 3.52
- Positive: Return on assets ratio (scaled to [-100,100]) of 8.16 > 6.06
- Negative: Industry operating profit margin (median), % of -0.78 <= 2.88
- Negative: Shareholder equity ratio, % of 65.51 > 64.29
- Negative: Industry operating cash flow per share per price (median), % of 2.19 <= 5.46
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Investing cash flow per share per price, % of -0.29 > -0.60
- Negative: Industry earnings per price (median), % of 0 <= 0
Short-term PATH quotes
Long-term PATH plot with estimates
Financial data
| YTD | 2024-01-31 | 2025-01-31 | 2026-01-31 |
|---|---|---|---|
| Operating Revenue | $1,308.07MM | $1,429.66MM | $1,610.57MM |
| Operating Expenses | $1,472.79MM | $1,592.23MM | $1,553.81MM |
| Operating Income | $-164.72MM | $-162.57MM | $56.76MM |
| Non-Operating Income | $88.91MM | $84.47MM | $43.87MM |
| R&D Expense | $332.10MM | $380.68MM | $385.21MM |
| Income(Loss) | $-75.81MM | $-78.10MM | $100.63MM |
| Taxes | $14.07MM | $-4.41MM | $-181.70MM |
| Net Income(Loss)* | $-89.88MM | $-73.69MM | $282.33MM |
| Stockholders Equity | $2,016.11MM | $1,845.76MM | $2,082.59MM |
| Assets | $2,954.76MM | $2,865.27MM | $3,179.20MM |
| Operating Cash Flow | $299.08MM | $320.56MM | $371.21MM |
| Capital expenditure | $7.34MM | $14.92MM | $19.05MM |
| Investing Cash Flow | $-439.57MM | $-45.50MM | $-22.47MM |
| Financing Cash Flow | $-196.90MM | $-450.51MM | $-372.38MM |
| Earnings Per Share** | $-0.16 | $-0.13 | $0.52 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.